instat v. 3.05 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
instat v. 3.05
Instat V. 3.05, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/instat+v+3%2E05/instat+version+3+05/pm40428411-93-6-10
Average 90 stars, based on 1 article reviews
Instat V. 3.05, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/instat+v+3%2E05/instat+version+3+05/pm40428411-93-6-10
Average 90 stars, based on 1 article reviews
instat v. 3.05 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Standard Deviation:Article Title: Comparison of lactate and β-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis. Article Snippet: Simple metabolites released during physical exercise and fasting like lactate (Lac) and β-hydroxybutyrate (BHB) have recently been shown to possess anti-inflammatory properties.. However, the effects of these metabolites in immune mediated hepatitis are still unknown.. Accordingly, we investigated the role of Lac, BHB and their combination on experimentally induced hepatic inflammation. Article Title: Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice. Article Snippet: Accepted Manuscript Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice Dalia H. El-Kashef, Marwa S. Serrya PII: S0024-3205(19)30365-0 DOI: https://doi.org/10.1016/j.lfs.2019.05.019 Reference: LFS 16463 To appear in: Life Sciences Received date: 14 March 2019 Revised date: 1 May 2019 Accepted date: 8 May 2019 Please cite this article as: D.H. El-Kashef and M.S.. Serrya, Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice, Life Sciences, https://doi.org/10.1016/j.lfs.2019.05.019 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis Article Snippet: All data were processed using Article Title: Development and validation of a screening tool for early identification of bloodstream infection in acute burn injury patients. Article Snippet: Descriptive statistics (mean with standard deviation or median, range, and percentage) and univariate analyses comparing Article Title: Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity. Article Snippet: In an attempt to explore the role of the JAK/STAT pathway in liver inflammation, we investigated the effect of intervening this pathway by ruxolitinib in thioacetamide (TAA)-induced hepatotoxicity.. Ruxolitinib treatments were administered to male mice either before or after intoxication with TAA.. The hepatic histopathological and serum biochemical assessment revealed that ruxolitinib pre-treatments dose-dependently reduced TAA-induced liver injury and caspase 3 cleavage and the number of hepatocytes positive for the pro-apoptotic Bax, as well as inflammatory cells positive for F4/80 and myeloperoxidase activity in the liver. Article Title: Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models Article Snippet: All data were processed using Article Title: Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases Article Snippet: Statistical tests were performed with Mann-Whitney U-Test:Article Title: Comparison of lactate and β-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis. Article Snippet: Simple metabolites released during physical exercise and fasting like lactate (Lac) and β-hydroxybutyrate (BHB) have recently been shown to possess anti-inflammatory properties.. However, the effects of these metabolites in immune mediated hepatitis are still unknown.. Accordingly, we investigated the role of Lac, BHB and their combination on experimentally induced hepatic inflammation. Article Title: Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice. Article Snippet: Accepted Manuscript Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice Dalia H. El-Kashef, Marwa S. Serrya PII: S0024-3205(19)30365-0 DOI: https://doi.org/10.1016/j.lfs.2019.05.019 Reference: LFS 16463 To appear in: Life Sciences Received date: 14 March 2019 Revised date: 1 May 2019 Accepted date: 8 May 2019 Please cite this article as: D.H. El-Kashef and M.S.. Serrya, Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice, Life Sciences, https://doi.org/10.1016/j.lfs.2019.05.019 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis Article Snippet: All data were processed using Article Title: Development and validation of a screening tool for early identification of bloodstream infection in acute burn injury patients. Article Snippet: Descriptive statistics (mean with standard deviation or median, range, and percentage) and univariate analyses comparing Article Title: Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity. Article Snippet: In an attempt to explore the role of the JAK/STAT pathway in liver inflammation, we investigated the effect of intervening this pathway by ruxolitinib in thioacetamide (TAA)-induced hepatotoxicity.. Ruxolitinib treatments were administered to male mice either before or after intoxication with TAA.. The hepatic histopathological and serum biochemical assessment revealed that ruxolitinib pre-treatments dose-dependently reduced TAA-induced liver injury and caspase 3 cleavage and the number of hepatocytes positive for the pro-apoptotic Bax, as well as inflammatory cells positive for F4/80 and myeloperoxidase activity in the liver. Article Title: Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models Article Snippet: All data were processed using Article Title: Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases Article Snippet: Statistical tests were performed with |